Modified 5-fluorouracil/leucovorin/irinotecan as a feasible and efficacious second-line chemotherapeutic regimen in advanced gastric cancers

BACKGROUND: Modified 5-fluorouracil/leucovorin/irinotecan (mFOLFIRI) is a commonly used combination second-line chemotherapeutic regimen in advanced gastric cancer (AGC). MATERIALS AND METHODS: Patients diagnosed with AGC, receiving biweekly mFOLFIRI between July 2013 and June 2016, as second-line c...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:South Asian J Cancer
Main Authors: Ramaswamy, Anant, Ostwal, Vikas, Gupta, Kushal, Simha, Vijai, Toshniwal, Anup, Shetty, Nitin, Nashikkar, Chaitali, Mandavkar, Sarika, Gupta, Sudeep
פורמט: Artigo
שפה:Inglês
יצא לאור: Medknow Publications & Media Pvt Ltd 2018
נושאים:
ORIGINAL ARTICLE: GI Cancers
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6190392/
https://ncbi.nlm.nih.gov/pubmed/30430086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/sajc.sajc_232_17
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים